在不同的疾病活动下,鉴定肠道微生物群在类类动物中的失生症
Xiaomin Hu1, Qingyang Wu2, Yue Fan2
1Department of Medical Research Center, State Key Laboratory for Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
肠道微生物群 (GM) 概况随着型皮虫 (BP) 活动而变化. 像Prevotella copri这样的特定细菌在血压开始时增加,在缓解期间减少,为疾病动态提供了洞察力.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
背景情况:
- 球状皮虫 (BP) 是一种严重的自身免疫性水泡性疾病,影响患者的生活质量.
- 肠道微生物群 (GM) 失调与各种自身免疫性疾病有关,但其在血压发作和缓解中的特定作用需要系统地调查.
研究的目的:
- 系统地调查肠道微生物群组成和型皮虫 (BP) 疾病活性之间的关系.
- 为了确定与BP发病和缓解阶段相关的动态GM配置文件.
主要方法:
- 从24名血压发病患者,24名血压缓解患者和24名健康对照患者的便样本进行16S rRNA测序.
- 分析微生物结构,在家族和安普利康序列变体 (ASV) 水平上的丰度,以及与临床参数的相关性.
主要成果:
- 在BP发作,缓解和健康组之间观察到不同的GM结构.
- 在BP组中,Bacteroidaceae,Ruminococcaceae和Enterobacteriaceae更为丰富,而Lachnospiraceae,Prevotellaceae和Veillonellaceae在健康和BP缓解组中更为丰富.
- 特定的ASVs,包括减少的Bacteroides ovatus和Veillonella dispar,以及增加的Prevotella copri,被确定为BP和缓解阶段之间的歧视性生物标志物.
结论:
- 肠道微生物群的组成随着型皮虫病的活动而动态变化.
- 这些发现为了解转基因在BP病原体中的作用和潜在的治疗策略提供了基础.
更多相关视频
05:28Analysis of Fecal Microbiota Dynamics in Lupus-Prone Mice Using a Simple, Cost-Effective DNA Isolation Method
Published on: May 2, 2022
08:24Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
相关概念视频
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...